Optiscan Imaging Limited (AU:OIL) has released an update.
Optiscan Imaging Ltd has unveiled InVue™, a revolutionary microscopic medical imaging device intended to transform precision surgery. This device is set to improve real-time decision-making for surgeons, particularly in cancer diagnosis and treatment, by offering instant digital pathology insights during operations. Its design promises to streamline the pathology process, improve diagnostic accuracy, and potentially lower healthcare costs while improving patient outcomes.
For further insights into AU:OIL stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
